Bharat Biotech
Bharat Biotech is a pioneering biotechnology company focused on innovative vaccine development and manufacturing. Their mission is to deliver affordable, safe, and high-quality vaccines and bio-therapeutics to help people prevail over diseases, with a focus on emerging markets. They are committed to leading innovation in biotechnology and have a rich history of research, development, and global collaborations.
Industries
Nr. of Employees
large (251-1000)
Bharat Biotech
Hyderabad, Andhra Pradesh, India, Asia
Products
Inactivated whole-virion COVID-19 vaccine (2-dose, refrigerated)
Inactivated whole-virion vaccine produced in high-containment facilities, formulated with adjuvant and supplied as a refrigerated liquid presentation for a two-dose primary series.
Oral rotavirus vaccine (oral liquid formulation)
Oral rotavirus vaccine delivered as a single-dose liquid presentation suitable for mass immunization campaigns.
Rabies vaccine (inactivated/parenteral relaunch)
Parenteral rabies vaccine product reintroduced for supply to immunization programs and healthcare providers to address local shortages.
Typhoid conjugate vaccine (conjugate presentation)
Conjugate vaccine combining capsular polysaccharide antigens with carrier protein to elicit T-cell dependent immune responses suitable for infants and older age groups; deployed following international regulatory engagement.
Inactivated whole-virion COVID-19 vaccine (2-dose, refrigerated)
Inactivated whole-virion vaccine produced in high-containment facilities, formulated with adjuvant and supplied as a refrigerated liquid presentation for a two-dose primary series.
Oral rotavirus vaccine (oral liquid formulation)
Oral rotavirus vaccine delivered as a single-dose liquid presentation suitable for mass immunization campaigns.
Rabies vaccine (inactivated/parenteral relaunch)
Parenteral rabies vaccine product reintroduced for supply to immunization programs and healthcare providers to address local shortages.
Typhoid conjugate vaccine (conjugate presentation)
Conjugate vaccine combining capsular polysaccharide antigens with carrier protein to elicit T-cell dependent immune responses suitable for infants and older age groups; deployed following international regulatory engagement.
Services
International business development and export supply
Support for international product registration, market authorization activities, partnerships for market access, and management of global supply of vaccines and biologics.
Clinical research and trial management
End-to-end clinical trial services including protocol development, multi-phase trial conduct, site monitoring, and ethical oversight.
Contract manufacturing and scale-up for vaccines
Manufacturing services using high-containment facilities and cell-culture platforms, including formulation, fill–finish (including pre-filled syringes) and packaging for global distribution.
Partnerships, licensing and technology transfer services
Support for collaborative R&D agreements, licensing arrangements, and transfer of manufacturing technology to partners and contract manufacturers.
International business development and export supply
Support for international product registration, market authorization activities, partnerships for market access, and management of global supply of vaccines and biologics.
Clinical research and trial management
End-to-end clinical trial services including protocol development, multi-phase trial conduct, site monitoring, and ethical oversight.
Contract manufacturing and scale-up for vaccines
Manufacturing services using high-containment facilities and cell-culture platforms, including formulation, fill–finish (including pre-filled syringes) and packaging for global distribution.
Partnerships, licensing and technology transfer services
Support for collaborative R&D agreements, licensing arrangements, and transfer of manufacturing technology to partners and contract manufacturers.
Expertise Areas
- Vaccine development and manufacturing
- Clinical trial management and human challenge trials
- Cell-culture and inactivated vaccine platforms
- Recombinant protein and conjugate vaccine R&D
Key Technologies
- BSL-3 containment facilities
- Whole-virion inactivated vaccine platform
- Mammalian cell culture production (Vero, MDCK)
- Recombinant protein expression